Literature DB >> 20154581

Plasma and cervical viral loads among Ugandan and Zimbabwean women during acute and early HIV-1 infection.

Charles S Morrison1, Korey Demers, Cynthia Kwok, Stanley Bulime, Anne Rinaldi, Marshall Munjoma, Megan Dunbar, Tsungai Chipato, Josaphat Byamugisha, Barbara Van Der Pol, Eric Arts, Robert A Salata.   

Abstract

OBJECTIVES: High levels of HIV-1 viremia exist in peripheral blood during acute and early infection; however, data on HIV-1 viral loads in female genital secretions during this period are sparse.
DESIGN: Prospective cohort of 188 African women with primary HIV-1 infection.
METHODS: HIV-uninfected and infected women were followed quarterly; we tested serial plasma specimens by HIV PCR to estimate infection dates. We used the Loess procedure to estimate the magnitude and timing of viral setpoints in plasma and cervical secretions and generalized estimating equations (GEE) to identify predictors of plasma and cervical viral setpoints.
RESULTS: We estimated the mean HIV-1 plasma setpoint to be 4.20 log10 HIV-1 RNA copies/ml [95% confidence interval (CI) 4.04-4.35] at 121 days (95% CI 91-137) from infection; an analogous mean cervical viral setpoint was 1.64 log10 HIV-1 RNA copies/swab (95% CI 1.46-1.82) at 174 days (95% CI 145-194) from infection. Cervical loads were significantly higher (0.7-1.1 log10 copies/swab) during acute infection than subsequently. Subtype D infection, pregnancy, breastfeeding, and older age at the time of infection were associated with higher plasma viral setpoint. Subtype C infection, nonviral sexually transmitted infections, having a partner spending nights away from home, recent unprotected sex, and shorter time since infection were associated with higher cervical HIV-1 loads. Hormonal contraception was not associated with either the HIV-1 plasma setpoint or cervical loads during early infection.
CONCLUSION: Cervical HIV-1 viral loads were highest during acute infection and then declined up to 6 months following infection, when a 'setpoint' was attained. The prognostic value of a cervical 'setpoint' on future transmission risk remains unclear.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20154581      PMCID: PMC3148071          DOI: 10.1097/QAD.0b013e32833433df

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  42 in total

1.  Comparison of techniques for HIV-1 RNA detection and quantitation in cervicovaginal secretions.

Authors:  G C John; H Sheppard; D Mbori-Ngacha; R Nduati; D Maron; M Reiner; J Kreiss
Journal:  J Acquir Immune Defic Syndr       Date:  2001-02-01       Impact factor: 3.731

2.  Effect of menstrual cycle on HIV-1 levels in the peripheral blood and genital tract. WHS 001 Study Team.

Authors:  P S Reichelderfer; R W Coombs; D J Wright; J Cohn; D N Burns; S Cu-Uvin; P A Baron; M H Coheng; A L Landay; S K Beckner; S R Lewis; A A Kovacs
Journal:  AIDS       Date:  2000-09-29       Impact factor: 4.177

3.  Determinants of HIV-1 shedding in the genital tract of women.

Authors:  A Kovacs; S S Wasserman; D Burns; D J Wright; J Cohn; A Landay; K Weber; M Cohen; A Levine; H Minkoff; P Miotti; J Palefsky; M Young; P Reichelderfer
Journal:  Lancet       Date:  2001-11-10       Impact factor: 79.321

4.  Initial plasma HIV-1 RNA levels and progression to AIDS in women and men.

Authors:  T R Sterling; D Vlahov; J Astemborski; D R Hoover; J B Margolick; T C Quinn
Journal:  N Engl J Med       Date:  2001-03-08       Impact factor: 91.245

5.  The effect of hormonal contraception on genital tract shedding of HIV-1.

Authors:  Chia C Wang; R Scott McClelland; Julie Overbaugh; Marie Reilly; Dana DeVange Panteleeff; Kishorchandra Mandaliya; Bhavna Chohan; Ludo Lavreys; Jeckoniah Ndinya-Achola; Joan K Kreiss
Journal:  AIDS       Date:  2004-01-23       Impact factor: 4.177

6.  Injectable contraceptive use and genital ulcer disease during the early phase of HIV-1 infection increase plasma virus load in women.

Authors:  Ludo Lavreys; Jared M Baeten; Joan K Kreiss; Barbra A Richardson; Bhavna H Chohan; Wisal Hassan; Dana D Panteleeff; Kishorchandra Mandaliya; Jeckoniah O Ndinya-Achola; Julie Overbaugh
Journal:  J Infect Dis       Date:  2004-01-09       Impact factor: 5.226

7.  Independent levels of cell-free and cell-associated human immunodeficiency virus-1 in genital-tract secretions of clinically asymptomatic, treatment-naive African women.

Authors:  Laurent Andréoletti; Nicolas Chomont; Gérard Grésenguet; Mathieu Matta; Jean de Dieu Longo; Marie-Paule Carreno; Ali Si-Mohamed; Jérôme Legoff; Michel D Kazatchkine; Laurent Bélec
Journal:  J Infect Dis       Date:  2003-07-29       Impact factor: 5.226

8.  Comparison of human immunodeficiency virus type 1 viral loads in Kenyan women, men, and infants during primary and early infection.

Authors:  Barbra A Richardson; Dorothy Mbori-Ngacha; Ludo Lavreys; Grace C John-Stewart; Ruth Nduati; Dana D Panteleeff; Sandra Emery; Joan K Kreiss; Julie Overbaugh
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

9.  Brief but efficient: acute HIV infection and the sexual transmission of HIV.

Authors:  Christopher D Pilcher; Hsiao Chuan Tien; Joseph J Eron; Pietro L Vernazza; Szu-Yun Leu; Paul W Stewart; Li-Ean Goh; Myron S Cohen
Journal:  J Infect Dis       Date:  2004-04-28       Impact factor: 5.226

10.  The relationship of pregnancy to human immunodeficiency virus disease progression.

Authors:  Howard Minkoff; Ron Hershow; D Heather Watts; Margaret Frederick; Irene Cheng; Ruth Tuomala; Jane Pitt; Carmen D Zorrilla; Hunter Hammill; Samuel K Adeniyi-Jones; Bruce Thompson
Journal:  Am J Obstet Gynecol       Date:  2003-08       Impact factor: 8.661

View more
  45 in total

1.  ART influences HIV persistence in the female reproductive tract and cervicovaginal secretions.

Authors:  Rikke Olesen; Michael D Swanson; Martina Kovarova; Tomonori Nochi; Morgan Chateau; Jenna B Honeycutt; Julie M Long; Paul W Denton; Michael G Hudgens; Amy Richardson; Martin Tolstrup; Lars Østergaard; Angela Wahl; J Victor Garcia
Journal:  J Clin Invest       Date:  2016-02-08       Impact factor: 14.808

2.  Hormonal contraceptive use and HIV disease progression among women in Uganda and Zimbabwe.

Authors:  Charles S Morrison; Pai-Lien Chen; Immaculate Nankya; Anne Rinaldi; Barbara Van Der Pol; Yun-Rong Ma; Tsungai Chipato; Roy Mugerwa; Megan Dunbar; Eric Arts; Robert A Salata
Journal:  J Acquir Immune Defic Syndr       Date:  2011-06-01       Impact factor: 3.731

Review 3.  Antiretroviral therapy: a key component of a comprehensive HIV prevention strategy.

Authors:  Mark W Hull; Julio Montaner
Journal:  Curr HIV/AIDS Rep       Date:  2011-06       Impact factor: 5.071

4.  High discordance in blood and genital tract HIV-1 drug resistance in Indian women failing first-line therapy.

Authors:  Shanmugam Saravanan; Selvamurthi Gomathi; Allison Delong; Bagavathi Kausalya; Sathasivam Sivamalar; Selvamuthu Poongulali; Katherine Brooks; Nagalingeswaran Kumarasamy; Pachamuthu Balakrishnan; Sunil S Solomon; Susan Cu-Uvin; Rami Kantor
Journal:  J Antimicrob Chemother       Date:  2018-08-01       Impact factor: 5.790

5.  Comparison of antibody responses to HIV infection in Ugandan women infected with HIV subtypes A and D.

Authors:  Andrew F Longosz; Charles S Morrison; Pai-Lien Chen; Hilmarie H Brand; Eric Arts; Immaculate Nankya; Robert A Salata; Thomas C Quinn; Susan H Eshleman; Oliver Laeyendecker
Journal:  AIDS Res Hum Retroviruses       Date:  2014-11-19       Impact factor: 2.205

6.  Immune responses in Ugandan women infected with subtypes A and D HIV using the BED capture immunoassay and an antibody avidity assay.

Authors:  Andrew F Longosz; Charles S Morrison; Pai-Lien Chen; Eric Arts; Immaculate Nankya; Robert A Salata; Veronica Franco; Thomas C Quinn; Susan H Eshleman; Oliver Laeyendecker
Journal:  J Acquir Immune Defic Syndr       Date:  2014-04-01       Impact factor: 3.731

7.  Incident pregnancy and pregnancy outcomes among HIV-infected women in Uganda and Zimbabwe.

Authors:  Kathryn E Lancaster; Cynthia Kwok; Anne Rinaldi; Josaphat Byamugisha; Tulani Magwali; Prisca Nyamapfeni; Robert A Salata; Charles S Morrison
Journal:  Int J Gynaecol Obstet       Date:  2015-09-08       Impact factor: 3.561

8.  Changes in HIV-1 subtypes B and C genital tract RNA in women and men after initiation of antiretroviral therapy.

Authors:  Susan A Fiscus; Susan Cu-Uvin; Abel Tilahun Eshete; Michael D Hughes; Yajing Bao; Mina Hosseinipour; Beatriz Grinsztejn; Sharlaa Badal-Faesen; Joan Dragavon; Robert W Coombs; Ken Braun; Laura Moran; James Hakim; Timothy Flanigan; N Kumarasamy; Thomas B Campbell
Journal:  Clin Infect Dis       Date:  2013-03-26       Impact factor: 9.079

9.  Biomarkers of Cervical Inflammation and Immunity Associated with Cervical Shedding of HIV-1.

Authors:  Christine Mauck; Pai-Lien Chen; Charles S Morrison; Raina N Fichorova; Cynthia Kwok; Tsungai Chipato; Robert A Salata; Gustavo F Doncel
Journal:  AIDS Res Hum Retroviruses       Date:  2016-01-26       Impact factor: 2.205

10.  Is there an association between HIV-1 genital shedding and cervical intraepithelial neoplasia 2/3 among women on antiretroviral therapy?

Authors:  Megan Justine Huchko; Victoria Woo; Teri Liegler; Anna Leddy; Karen Smith-McCune; George F Sawaya; Elizabeth A Bukusi; Craig R Cohen
Journal:  J Low Genit Tract Dis       Date:  2013-07       Impact factor: 1.925

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.